Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhengyan Liang
Institutions:
Second Military Medical University,
Shanghai Changzheng Hospital,
Yunnan University of Traditional Chinese Medicine
Observed institutions:
Second Military Medical University,
Shanghai Changzheng Hospital,
Yunnan University of Traditional Chinese Medicine,
Yangzhou University
ORCID:
0009-0009-6135-3372
Observed ORCID:
0009-0009-6135-3372
OpenAlex ID:
A5036005181
Neoantigens and NK Cells: “Trick or Treat” the Cancers?
2022
·
Dan Lv
, Muhammad Babar Khawar
, et al.
·
Frontiers in Immunology
·
12
PDF
A Comprehensive Analysis Revealing FBXW9 as a Potential Prognostic and Immunological Biomarker in Breast Cancer
2023
·
Shiyi Yu
, Zhengyan Liang
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
Schisandrin B exerts anti-colorectal cancer effect through CXCL2/ERK/DUSP11 signaling pathway
2025
·
Jianguo Sun
, Zhipeng Wang
, et al.
·
Cancer Cell International
·
4
Development and Validation of a Rapid LC-MS/MS Method for Carfilzomib Quantification in Plasma from Multiple Myeloma Patients
2026
·
Zhengyan Liang
, Jing Qian
, et al.
·
Journal of Visualized Experiments
An LC‐MS/MS Method for Quantitative Analysis of Regorafenib and Exploration of Its Intracellular Exposure in Colorectal Cancer Cells
2026
·
Xinran Wang
, Wenwen Cai
, et al.
·
International Journal of Analytical Chemistry
PDF
Development of an Early-Warning Model for Predicting the Capecitabine-Induced Diarrhea
2025
·
Zhijun Liu
, Shi Qiu
, et al.
·
Drug Design Development and Therapy
PDF
Quantification of β‐Elemene by GC–MS and Preliminary Evaluation of Its Relationship With Antitumor Efficacy in Cancer Patients
2025
·
Juanjuan Hou
, Jia Yi
, et al.
·
Journal of Analytical Methods in Chemistry
PDF
Show more works
View as search
Works count:
7
Citation count:
24
H-index:
3
I10-index:
1
Year
Topic
Type